These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical and prognostic values of anti-hepatitis B core immunoglobulin M detection in asymptomatic hepatitis B surface antigen carriers. Ali HY, Faransawy ZE, Al-Megthab NA. Saudi Med J; 2002 Jul; 23(7):777-81. PubMed ID: 12174223 [Abstract] [Full Text] [Related]
25. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study. Ramakrishna B, Mukhopadhya A, Kurian G. J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304 [Abstract] [Full Text] [Related]
26. Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment. Gérolami R, Henry M, Borentain P, Colson P, Botta D, Tamalet C. Clin Infect Dis; 2005 Feb 15; 40(4):e24-7. PubMed ID: 15712066 [Abstract] [Full Text] [Related]
27. [Occult hepatitis B virus infection in chronic viral hepatitis patients with non-A to E hepatitis virus infection]. Shang QH, Yu JG, Xu CZ, An Y, Liu FY, Sun SC, Zhang GS. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec 15; 22(6):440-2. PubMed ID: 19544639 [Abstract] [Full Text] [Related]
28. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma. Wu JM, Huang YH, Lee PC, Lin HC, Lee SD. J Clin Gastroenterol; 2009 Dec 15; 43(5):496-8. PubMed ID: 19247200 [Abstract] [Full Text] [Related]
31. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT. Panhotra BR, Bahrani A, Joshi CS, ul Hassan Z. J Infect; 2005 Oct 15; 51(3):263. PubMed ID: 16125778 [No Abstract] [Full Text] [Related]
32. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C. Matsuoka S, Nirei K, Tamura A, Nakamura H, Matsumura H, Oshiro S, Arakawa Y, Yamagami H, Tanaka N, Moriyama M. Intervirology; 2008 Oct 15; 51(5):352-61. PubMed ID: 19127078 [Abstract] [Full Text] [Related]
33. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation]. Chen H, Zhu QR. Zhonghua Gan Zang Bing Za Zhi; 2003 Apr 15; 11(4):240. PubMed ID: 12716528 [No Abstract] [Full Text] [Related]
34. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH. Korean J Hepatol; 2008 Mar 15; 14(1):67-76. PubMed ID: 18367859 [Abstract] [Full Text] [Related]
38. Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-gamma production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity. Niigaki M, Fukuda R, Hamamoto S, Ishimura N, Ishihara S, Akagi S, Watanabe M, Kinoshita Y. Am J Gastroenterol; 2000 Jan 15; 95(1):239-47. PubMed ID: 10638591 [Abstract] [Full Text] [Related]